Achillea millefolium is a plant used as a component of anti-diabetic preparation but the bioactive compounds responsible for its use are not known. Inhibition of intestinal α-glucosidase is a preferable effect for prevention and treatment of diabetes, and A. millefolium extract showed inhibitory activity against the enzyme. Activity-guided separation of the extract gave four mono-or di-caffeoylquinic acids as the isolate. Quantitation of these four caffeoylquinic acids and the activity of the isolates suggested that these are the major contributor for the α-glucosidase inhibitory activity in the extract. However also, the presence of unidentified, minor, but potent α-glucosidase inhibitor in the isolate was also suggested.
Achillea millefolium, commonly named yarrow, is a perennial herbal plant belonging to the Asteraceae family. The plant is native to the regions of Northern Hemisphere including Eastern Asia to Europe. The plant is commonly consumed as an herbal tea or prepared as an essential oil [1] . The traditional use of this plant includes the treatment of inflammatory and spasmodic gastrointestinal disorders, for wound healing, skin inflammations or as an appetite-enhancing drug [2, 3] , and also as a component of antidiabetic preparation [4, 5] . Recent scientific studies on this plant revealed sesquiterpenes as an active ingredient related to the antiphlogistic activity [6] , di-caffeoylquinic acids as the choleretic substances [7] , which are assumed to be related to antiinflammatory properties and problems in digestive tracts. However, the active compound related to the antidiabetic property of A. millefolium has not been reported. Here, we searched for the intestinal α-glucosidase inhibitor from the extract of A. millefolium, and found several dicaffeoylquinic acids as the active component, which may contribute at least in part to the antidiabetic property of this plant.
The dried aerial part of A. millefolium was extracted with aqueous methanol. The extract showed 55% inhibition at 1.6 mg/mL against rat intestinal α-glucosidase and was separated with a guidance of the activity. The extract was partitioned between water, ethyl acetate and 1-butanol. The 1-butanol soluble part was further purified by DIAION HP-20, and TOYOPEARL DEAE 650M column chromatography. The obtained fractions were finally separated by HPLC using Inertsil ODS-3 column to obtain compound 1-4.
Each compound was analyzed by 1 H-NMR and mass spectrometry to determine the structure. 1 H-NMR spectrum revealed that these Figure 1 ) [8, 9] .
An inhibitory activity of 1-4 was next measured ( Figure 2 ). Among the four caffeoylquinic acids, 2 showed the highest activity with 69% inhibition at 0.5 mM. Compounds 3 and 4 showed weaker activity compared to 2 and chlorogenic acid (1) showed the least activity. To evaluate a contribution of 1-4 in the activity of the A. millefolium extract, a concentration of each compound in the extract was measured by HPLC (Table 1) . Then, an inhibitory activity of the individual compounds, the mixture of compounds, and the extract was compared at the concentration adjusted according to Table 1 (Figure 3 ). The mixture shows slightly weaker activity compared to an inhibitory activity of the extract, indicating that these isolated compounds are the major contributor to the inhibition of α-glucosidase by the A. millefolium extract. However, when the activity was compared with the previous reports, there is an another speculation [9, 10] . α-Glucosidase inhibitory activity of di-caffeoylquinic acids are shown in several articles [9] [10] [11] . Reported IC 50 values are 1-2 mM, depending on the assay procedure, which is in reasonable comparison with the current measured inhibitory activity for compound 3 and 4. In comparison, compound 2 in the current study shows quite high activity compared to the reported IC 50 values (35% at 0.016 mM, Figure 3 ). Therefore, the fact suggests there may be a contribution of minor component included in 2 for the activity.
The α-glucosidase inhibitory activity of caffeoylquinic acids are known to highly depend on the number of caffeoyl groups attached to the quinic acid moiety. Tri-caffeoylquinic acids are reported to show much lower IC 50 value compared to the di-caffeoylquinic acids [10, 11] . Since di-and tri-caffeoylquinic acids are related natural products, we analyzed the tested sample by MS to check if tri-caffeoylquinic acid is included. However no peaks were identified indicating the presence of tri-caffeoylquinic acid.
Presence of caffeoylquinic acids in various taxa and commercial products of A. millefolium are reported [12, 13] . Caffeoylquinic acids are known to inhibit AGEs formation [14] , enhance glucagonlike peptide-1 secretion [15] , and increase insulin stimulated glucose uptake of adipocytes and myotubes [16, 17] . These activities, as well as α-glucosidase inhibition, are all related to a treatment or a prevention of diabetes, indicating a importance of caffeoylquinic acid in anti-diabetic property.
In conclusion, α-glucosidase inhibitor in the A. millefolium extract was investigated in relationship with the plant use as a component of anti-diabetic preparation. A. millefolium contained several caffeoylquinic acids (1) (2) (3) (4) which are reported as α-glucosidase inhibitory compound. The mixture of these compounds showed comparable activity to the extract. However, the activity of 2 was much stronger than that in the previous reports. Therefore, there may be a more potent inhibitor in the extract of A. millefolium, but various activities of caffeoylquinic acids still indicates importance of this compound in anti-diabetic property of the plant.
Experimental
General: All commercially available chemicals were purchased from Wako Pure Chem. Ind. Ltd., unless otherwise noted. Achillea millefolium was purchased from Hyakka-Saen.Co.Ltd. Structures of the compounds were determined by NMR and Mass spectrometry. Bruker AMX500 or Jeol JNM-EX 270 was used to obtain NMR spectrum and residual solvent peak was used as an internal standard (methanol-d 4 3.31 ppm). LCT-premier (Waters Co.) was used to obtain mass spectrum. Absorbance was measured by Synergy TM MX (Bio-tech Instruments Inc.) microplate reader.
Isolation: Powdered Achillea millefolium (900 g) was extracted with 50% aq. methanol for 24 hr. The extract (144 g) was dispersed in water and partitioned between ethyl acetate and then between 1butanol. The 1-butanol layer (23.4 g) was concentrated and the residual aq. solution was separated by DIAION HP-20 (Mitsubishi Chemical Co., Tokyo) column chromatography with stepwise elution (water, 50% aq. methanol, and methanol). The 50% aq. methanol eluate (9.5 g) was absorbed to TOYOPEARL DEAE 650 (Tosoh Co., Tokyo) and washed with 50% aq. methanol. The gel was eluted by 8% acetic acid/50% aq. methanol (Fr. 1, 4.10 g) and then with 0.1 M sodium chloride/50% aq. methanol (Fr. 2, 1.57 g). Fr. 1 (16.5 mg) was purified by HPLC [Inertsil ODS-3 (GL Science Co., Tokyo), 30% aq. methanol with 0.1% trifluoroacetic acid (TFA)]. A peak eluted at tR = 31.7 min was collected to obtain compound 1 (7.3 mg). Fr. 2 (40 mg) was purified by HPLC (Inertsil ODS-3, 50% aq. MeOH with 0.1% TFA) and a peak eluted at tR = 18.0 min was collected. This peak (18.6 mg) was further purified by HPLC (Inertsil ODS-3, 40% aq. MeOH with 0.1% TFA) and the peaks eluted at tR = 74.4, 82.9, 102.5 min was collected to obtain compound 2 (1.5 mg), 3 (5.5 mg), and 4 (3.3 mg). ( α-Glucosidase inhibitory activity: Rat intestinal acetone powder (1 g, Sigma-Aldrich Co.) was homogenized in 20 mL of 0.1 M phosphate buffer (pH 7.0, 5 mM EDTA), centrifuged (15,000 g × 10 min) and the supernatant was used as the crude enzyme. The reaction mixture consisting from the crude enzyme (20 μL), substrate (8 mM maltose in phosphate buffer, 25 μL) and the test sample (dissolved in 50% aq. DMSO, 5 μL) was mixed and incubated at 37 °C for 20 min. The reaction was stopped by adding 75 μL of 2 M Tris-HCl buffer (pH 7.0), diluted with the phosphate buffer (375 μL) and then passed through a short column of Cosmosil 75C18-OPN (Nacalai Tesque, Inc.) to remove the test sample. The amount of liberated glucose was measured by Glucose CII-test Wako and compared with the control value to determine the inhibitory activity. Each experiment was done in duplicate and repeated at least twice. The average of experiments is shown in the figure. 
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